Loading…
ABIVAX Société Anonyme is projected to rise to $166.39 by 2027, a +19% move from its current price of $139.90. ABVX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $130.92 | $139.92 | $149.53 | +0.01% |
| Jul 14 | $127.38 | $139.93 | $153.72 | +0.02% |
| Jul 15 | $124.73 | $139.95 | $157.02 | +0.04% |
| Jul 16 | $122.55 | $139.97 | $159.87 | +0.05% |
| Jul 17 | $120.66 | $139.99 | $162.41 | +0.06% |
| Jul 18 | $118.97 | $140.00 | $164.75 | +0.07% |
| Jul 19 | $117.44 | $140.02 | $166.94 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $117.44 | $140.02 | $166.94 | +0.09% |
| Week 2 | $109.29 | $140.14 | $179.70 | +0.17% |
| Week 3 | $103.44 | $140.26 | $190.19 | +0.26% |
| Week 4 | $98.76 | $140.38 | $199.54 | +0.34% |
| Week 5 | $94.83 | $140.50 | $208.18 | +0.43% |
| Week 6 | $91.41 | $140.62 | $216.32 | +0.52% |
| Week 7 | $88.39 | $140.74 | $224.11 | +0.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ABIVAX Société Anonyme is a clinical-stage biotechnology company that develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
Its lead drug candidate obefazimod is in Phase 3 clinical development for moderately to severely active ulcerative colitis and in Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
ABVX trades at $144.65 per share.
It has a market capitalization of $11.54B and is ranked 828.
The forecast path shows a rising trajectory with the average price reaching $144.65 in 2026 and advancing to $421.44 by 2030 and $3,295.96 by 2050, with ROIs climbing from 0 to 191.3 by 2030 and to 2178.6 by 2050.
A major floor 66.5% below — a decisive break under it would weaken the trend.
The nearest floor, 48.2% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 36.6% above — clearing it would confirm fresh momentum.
Key ABVX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABVX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $141.07 | Sell | $138.54 | Buy |
| MA 10 | $130.95 | Buy | $131.51 | Buy |
| MA 20 | $114.35 | Buy | $122.41 | Buy |
| MA 50 | $115.13 | Buy | $116.67 | Buy |
| MA 100 | $116.49 | Buy | $114.78 | Buy |
| MA 200 | $113.50 | Buy | $104.20 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.21 | Neutral |
| Stoch RSI (14) | 83.84 | Sell |
| CCI (20) | 84.74 | Neutral |
| Williams %R (14) | -9.09 | Info |
| MACD (12,26,9) | 4.28 | Buy |
| ROC (12) | 42.13 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 90.91 | Sell |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 27.77 | Buy |
| Ultimate (7,14,28) | 66.44 | Neutral |
| Momentum (10) | 47.53 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 143.28 | Sell |
| ADX (14) | 23.43 | Buy |
| ATR (14) | 5.13 | Info |
The 30-day technical picture shows a bullish sentiment with RSI14 at 70, and price action around the major moving averages. SMA50 is $112.33 and SMA200 is $112.02, outlining a constructive setup.
Key support sits at $72.50 and resistance at $144.65, with the 30-day range spanning $86.98 to $240.55. The asset exhibits high variability, with annualized volatility at 100.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $72.50 | $139.90 | $222.25 | 0% | Neutral | |
| $120.73 | $166.39 | $247.95 | +19% | Neutral | |
| $156.76 | $229.61 | $364.61 | +64% | Bullish | |
| $201.72 | $311.23 | $518.86 | +122% | Bullish | |
| $250.16 | $404.64 | $702.23 | +189% | Bullish | |
| $305.33 | $516.17 | $927.31 | +269% | Bullish | |
| $267.34 | $471.40 | $873.19 | +237% | Bullish | |
| $261.79 | $480.74 | $915.25 | +244% | Bullish | |
| $322.95 | $616.92 | $1,204.23 | +341% | Bullish | |
| $387.19 | $768.81 | $1,535.63 | +450% | Bullish | |
| $491.91 | $1,093.14 | $2,399.65 | +681% | Bullish | |
| $1,445.21 | $3,211.59 | $7,386.65 | +22.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $72.50 | $139.90 | $177.41 | +0.00% |
| August 2026 | $121.57 | $147.25 | $185.74 | +5.25% |
| September 2026 | $115.16 | $141.47 | $182.21 | -3.92% |
| October 2026 | $118.48 | $147.34 | $193.09 | +4.15% |
| November 2026 | $128.78 | $161.82 | $215.14 | +9.83% |
| December 2026 | $130.03 | $164.98 | $222.25 | +1.96% |
Click any year to see its month-by-month ABVX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ABVX to range from $72.50 to $222.25 through 2026. The $139.90 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ABVX price prediction for 2027 points to an average of $166.39 (low $120.73, high $247.95) — a potential gain of +19% on today's $139.90. A consolidation phase looks the most probable path here.
In 2028, ABVX is projected to trade between $156.76 and $364.61, averaging $229.61 — a potential gain of +64% from today's $139.90. That is up +38% on the projected 2027 average. Momentum favours further upside here.
ABIVAX Société Anonyme's 2029 outlook centres on $311.23, within a $201.72 to $518.86 range. That is up +36% on the projected 2028 average. That marks a +122% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ABVX could reach as high as $702.23, with a base case around $404.64 and support toward $250.16 — roughly +189% from $139.90. Momentum favours further upside here.
Expect ABVX to range from $305.33 to $927.31 through 2031. The $516.17 average target implies a +269% move from current prices. That is up +28% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ABVX price prediction for 2032 points to an average of $471.40 (low $267.34, high $873.19) — a potential gain of +237% on today's $139.90. Momentum favours further upside here.
In 2033, ABVX is projected to trade between $261.79 and $915.25, averaging $480.74 — a potential gain of +244% from today's $139.90. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
ABIVAX Société Anonyme's 2034 outlook centres on $616.92, within a $322.95 to $1,204.23 range. That is up +28% on the projected 2033 average. That marks a +341% change versus current levels. Momentum favours further upside here.
By 2035, ABVX could reach as high as $1,535.63, with a base case around $768.81 and support toward $387.19 — roughly +450% from $139.90. Buyers look set to stay in control over this stretch.
Expect ABVX to range from $491.91 to $2,399.65 through 2040. The $1,093.14 average target implies a +681% move from current prices. That is up +42% on the projected 2035 average. Momentum favours further upside here.
The ABVX price prediction for 2050 points to an average of $3,211.59 (low $1,445.21, high $7,386.65) — a potential gain of +22.0x on today's $139.90. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABVX today (≈ 7.147963 ABVX) could be worth
$22,956.31
+$21,956.31 (+2196%) by 2050 · US Dollar
Based on the average projected ABVX price of $3,211.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABVXwould be worth at today's price.
$1,000 invested in ABVX on Jul 10, 2025 (≈ 120.481925 ABVX) would be worth
$16,855.42
+$15,855.42 (+1585.5%) today · 16.86× · US Dollar
Based on a ABVX entry price of $8.3 vs. today's $139.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $144.65 | $967.16 | -3.3% |
| 1 month ago | $98.03 | $1,427.11 | +42.7% |
| 3 months ago | $126.14 | $1,109.09 | +10.9% |
| 6 months ago | $118 | $1,185.59 | +18.6% |
| 1 year ago | $8.3 | $16,855.42 | +1585.5% |
| All time (2.7y) ago | $8.3 | $16,855.42 | +1585.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABVX forecast.
Our base-case forecast reaches $280.00 around 2029.
Implied market cap at $280.00: $24.4B
Looking across the multi-year forecast, ABVX shows a strong upside through 2030 and beyond. The 2026 avg price is $144.65, rising to $421.44 in 2030 and then to $1,124.10 by 2040, before reaching $3,295.96 in 2050. Corresponding ROIs rise from 0 in 2026 to 191.3 in 2030, 677.1 in 2040, and 2178.6 in 2050, with bullish sentiment prevailing in 2027 and later years.
In 2031 the avg is $535.75 and in 2032 $477.83, continuing the upward trend into 2033 at $503.36 and beyond. By 2040 the avg reaches $1,124.10 and by 2050 the avg reaches $3,295.96, highlighting substantial long-term upside with notable uncertainty and volatility inherent in such projections.
These figures are estimates, not guarantees, and actual results may differ due to market and development outcomes.
Tap a question to reveal the answer.
In 2030, the avg price is forecast at $421.44, with a min of $260.26 and a max of $732.07; ROI is 191.3; sentiment is BULLISH.
Forecasts show a bullish sentiment from 2027 onward, with the avg price rising to $421.44 by 2030 and higher by 2040 and 2050, and ROI values such as 191.3 in 2030 and 2178.6 in 2050.
Yes. The forecast max reaches $2,468.60 in 2040 and $7,580.72 in 2050, indicating potential above $2,000 within the horizon.
The current price is $144.65 and the market capitalization is $11.54B.
The 30-day range is $86.98 to $240.55, RSI14 is 70, SMA50 is $112.33, SMA200 is $112.02, with support at $72.50 and resistance at $144.65.
ABIVAX Société Anonyme Community Discussion
0Share your ABIVAX Société Anonyme price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.